Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$6.1 - $7.15 $473,164 - $554,611
-77,568 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$5.93 - $7.6 $146,803 - $188,145
-24,756 Reduced 24.19%
77,568 $237,000
Q4 2021

Feb 14, 2022

SELL
$6.04 - $8.03 $17,014 - $22,620
-2,817 Reduced 2.68%
102,324 $398,000
Q3 2021

Nov 15, 2021

SELL
$8.02 - $11.0 $418,587 - $574,123
-52,193 Reduced 33.17%
105,141 $554,000
Q2 2021

Aug 16, 2021

SELL
$7.59 - $10.48 $885,176 - $1.22 Million
-116,624 Reduced 42.57%
157,334 $931,000
Q1 2021

May 12, 2021

SELL
$6.86 - $9.24 $1.38 Million - $1.86 Million
-201,042 Reduced 42.32%
273,958 $1.95 Million
Q4 2020

Feb 16, 2021

BUY
$5.0 - $7.5 $2.38 Million - $3.56 Million
475,000 New
475,000 $3.71 Million

About Cyclacel Pharmaceuticals, Inc.


  • Ticker CYCC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 12,539,200
  • Market Cap $4.64M
  • Description
  • Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. The company's development programs include fadraciclib, a cyclin dependent kinase Inhibitors (CDK) that is in Phase 1/2 clinical trial for the treatment of solid tumors, as well as in combin...
More about CYCC
Track This Portfolio

Track Pura Vida Investments, LLC Portfolio

Follow Pura Vida Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pura Vida Investments, LLC with notifications on news.